Literature DB >> 15549414

Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease.

Z A Massy1, C Mazière, S Kamel, M Brazier, G Choukroun, C Tribouilloy, M Slama, M Andrejak, J C Mazière.   

Abstract

Vascular and/or valvular calcifications in patients with chronic kidney disease (CKD) appear to indicate a poor prognosis in terms of overall survival and cardiovascular morbidity and mortality. Inflammation and oxidative stress represent new features of the arterial and/or valvular calcification process. However, only limited observational and epidemiological data are available in these areas. Therefore, the link between inflammation, oxidation and vascular and/or valvular calcifications deserves careful consideration in CKD patients, since they may become targets for the development of new therapeutic strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15549414     DOI: 10.1007/s00467-004-1623-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  37 in total

Review 1.  Vascular calcification--a passive process in need of inhibitors.

Authors:  T Schinke; G Karsenty
Journal:  Nephrol Dial Transplant       Date:  2000-09       Impact factor: 5.992

2.  Monocyte/macrophage regulation of vascular calcification in vitro.

Authors:  Yin Tintut; Jignesh Patel; Mary Territo; Trishal Saini; Farhad Parhami; Linda L Demer
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

3.  Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals.

Authors:  Robert Park; Robert Detrano; Min Xiang; Paul Fu; Youhanna Ibrahim; Laurie LaBree; Stanley Azen
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

4.  Phosphate regulation of vascular smooth muscle cell calcification.

Authors:  S Jono; M D McKee; C E Murry; A Shioi; Y Nishizawa; K Mori; H Morii; C M Giachelli
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

5.  C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis.

Authors:  M E Hunt; P G O'Malley; M N Vernalis; I M Feuerstein; A J Taylor
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

6.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Authors:  Markus Ketteler; Philipp Bongartz; Ralf Westenfeld; Joachim Ernst Wildberger; Andreas Horst Mahnken; Roland Böhm; Thomas Metzger; Christoph Wanner; Willi Jahnen-Dechent; Jürgen Floege
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

7.  Accelerated progression of calcific aortic stenosis in dialysis patients.

Authors:  Vlado Perkovic; David Hunt; Sian V Griffin; Moira du Plessis; Gavin J Becker
Journal:  Nephron Clin Pract       Date:  2003

8.  Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease.

Authors:  Noriyuki Sakata; Akiko Noma; Yuji Yamamoto; Kouji Okamoto; Jing Meng; Shigeo Takebayashi; Ryoji Nagai; Seikoh Horiuchi
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

9.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.

Authors:  J Braun; M Oldendorf; W Moshage; R Heidler; E Zeitler; F C Luft
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860

10.  Effects of cytokines and growth factors on phosphorylated fetuin biosynthesis by adult rat hepatocytes in primary culture.

Authors:  T Ohnishi; O Nakamura; N Arakaki; H Miyazaki; Y Daikuhara
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

View more
  18 in total

Review 1.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

Review 2.  Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature.

Authors:  Chang Hyun Byon; Yabing Chen
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

3.  Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients.

Authors:  Mohamed M Nasrallah; Amal R El-Shehaby; Noha A Osman; Mona M Salem; Amr Nassef; Usama A A Sharaf El Din
Journal:  Int Urol Nephrol       Date:  2011-06-04       Impact factor: 2.370

Review 4.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

5.  Diosgenin attenuates vascular calcification in chronic renal failure rats.

Authors:  Jeganathan Manivannan; T R Barathkumar; Jeganathan Sivasubramanian; Pandian Arunagiri; Boobalan Raja; Elumalai Balamurugan
Journal:  Mol Cell Biochem       Date:  2013-02-20       Impact factor: 3.396

6.  Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D3 and Nicotine in Rats Via Targeting TNF-α, IL-1β, iNOS, and Osteogenic Runx2.

Authors:  Ahmed E Amer; George S G Shehatou; Hassan A El-Kashef; Manar A Nader; Ahmed R El-Sheakh
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-26       Impact factor: 3.727

Review 7.  The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective.

Authors:  Paula Mosińska; Martin Storr; Jakub Fichna
Journal:  Therap Adv Gastroenterol       Date:  2015-09       Impact factor: 4.409

8.  Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification.

Authors:  Agneta Simionescu; Dan T Simionescu; Narendra R Vyavahare
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 9.  The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair.

Authors:  Parinaz Zivarpour; Željko Reiner; Jamal Hallajzadeh; Liaosadat Mirsafaei; Zatollah Asemi
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

10.  Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.

Authors:  Robert G Fassett; Ritza Driver; Helen Healy; Dwarakanathan Ranganathan; Sharad Ratanjee; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2009-03-12       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.